Feasibility and Acceptability of Group Pain Reprocessing Therapy for Veterans With Chronic Neck/Back Pain

Not Applicable

Completed

• Conditions: Chronic Pain; Back Pain; Chronic Back Pain; Neck Pain

• Registration Number: NCT06406699
• Lead Sponsor: University of Colorado, Denver

Brief Summary

The investigators are conducting a trial that evaluates the feasibility of telehealth group pain reprocessing therapy (PRT), with no comparison group, for the treatment of chronic back pain in a population of veterans. PRT is a psychotherapy for chronic pain that aims to help patients reconceptualize their pain as a non-dangerous signal. It has been shown to be effective in a previous RCT (n=151).

Detailed Description

Not available

Study Timeline

• Study Start: 2024-04-17
• Study First Submitted: 2024-05-06
• Study First Submitted QC: 2024-05-06
• Study First Posted: 2024-05-09
• Primary Completion: 2025-01-25
• Study Completion: 2025-02-08
• Status Verified: 2025-07
• Last Update Submitted: 2025-07-01
• Last Update Posted: 2025-07-03

Recruitment & Eligibility

• Status: COMPLETED
• Sex: All
• Target Recruitment: 46

Inclusion Criteria

• At least 6 months of back pain with last week average back pain at least 4/10
• Able to attend at least 7/8 telehealth group sessions
• Access to safe living space, quite room, reliable internet, and electronic device that can be used to attend telehealth therapy sessions.

Exclusion Criteria

• Leg pain that is worse than back pain
• Suicide attempt, SI, HI, or inpatient psychiatric hospitalization in the past 5 years
• Not receiving/has not received disability or workers compensation related to back pain in the past 2 years.
• Is not currently involved in litigation regarding chronic back pain.
• Current misuse or overuse of alcohol or drugs
• Major surgery or other major medical events in the next 6 months
• Known vertebral/spinal fracture or tumor.
• Back surgery within last 2 years
• Difficulty controlling bowel movements
• Current or recent diagnosis of cancer
• Current or recent diagnosis of severe cardiovascular disease
• Unexplained or unintended greater than 20 pound weight loss in the past year
• Diagnosis of rheumatoid arthritis, polymyalgia rheumatica, scleroderma, Lupus, polymyositis, or other specific inflammatory disorders

Study & Design

• Study Type: INTERVENTIONAL
• Study Design: SINGLE_GROUP

Primary Outcome Measures

Name	Time	Method
PEG-3 Average Pain in last week	Baseline, Post-treatment, and 2-months post-treatment	0-10 scale that asks participant to rate their average pain (0=No pain, 10=Pain as bad as possible) in the last week

Trial Locations

Locations (1)

University of Colorado - Anschutz Medical Campus VA; 🇺🇸 Aurora, Colorado, United States